Melanoma-Related Protein May Lead To Treatment Advancements

0 Shares

Melanoma-Related Protein May Lead To Treatment Advancements A newly discovered cell linked to melanoma tumor growth may help researchers better develop future treatments, according to findings published in Nature.

During a recent study, researchers examined cell samples taken from the melanoma cancer, which provided more accurate results compared to cultured cells. During analysis, investigators found CD271, a compound located in more than 16 percent of all samples that made up to 41 percent of the tumors.

After finding this protein, researchers administered cells with high levels of CD271 into mice that were genetically-altered to have poor immune systems. The results of the transplant showed that the animals that had cell growth on the skin increased the risk of cancer by 70 percent.

“This could be the reason why we often see melanoma patients relapsing and coming back to the clinic,” said Alexander Boiko, a post-doctoral fellow from the Stanford University School of Medicine. He added that targeting cells containing CD271 may lead to “a combination therapy [that] might work to kill both types of cells in the tumor and, hopefully, prevent disease recurrence.

These findings may bring researchers closer to increasing the survival rate of those who have developed the disease. In 2006, more than 8,400 Americans died from melanoma, according to the Centers for Disease Control and Prevention.ADNFCR-1960-ID-19890926-ADNFCR

Personal Liberty

Special To Personal Liberty

You Sound Off! is written by our readers and appears the last Wednesday of each month. If you would like to submit an article or letter to the editor for consideration for You Sound Off!, send it to yousoundoff@personalliberty.com by the Friday before the last Wednesday of the month. To be considered, a submission should be 750 words or less and must include the writer's name, address and a telephone number. Only the writer's name will be published. Anonymous submissions will not be considered.

Join the Discussion

Comment Policy: We encourage an open discussion with a wide range of viewpoints, even extreme ones, but we will not tolerate racism, profanity or slanderous comments toward the author(s) or comment participants. Make your case passionately, but civilly. Please don't stoop to name calling. We use filters for spam protection. If your comment does not appear, it is likely because it violates the above policy or contains links or language typical of spam. We reserve the right to remove comments at our discretion.